<code id='989480199B'></code><style id='989480199B'></style>
    • <acronym id='989480199B'></acronym>
      <center id='989480199B'><center id='989480199B'><tfoot id='989480199B'></tfoot></center><abbr id='989480199B'><dir id='989480199B'><tfoot id='989480199B'></tfoot><noframes id='989480199B'>

    • <optgroup id='989480199B'><strike id='989480199B'><sup id='989480199B'></sup></strike><code id='989480199B'></code></optgroup>
        1. <b id='989480199B'><label id='989480199B'><select id='989480199B'><dt id='989480199B'><span id='989480199B'></span></dt></select></label></b><u id='989480199B'></u>
          <i id='989480199B'><strike id='989480199B'><tt id='989480199B'><pre id='989480199B'></pre></tt></strike></i>

          leisure time

          leisure time

          author:comprehensive    Page View:1222
          J.P. Morgan office building at night -- JPM health business coverage from STAT
          Adobe

          SAN FRANCISCO — Almost three years ago, the country’s biggest bank unveiled a lofty plan to fix the health care industry’s entrenched problems. It broke off $250 million to stand up a new business unit, Morgan Health, to do so. 

          Today, Morgan Health’s CEO, Dan Mendelson, aided by a newly hired flack, emailed reporters attending that bank’s annual investor confab, the J.P. Morgan Healthcare Conference, asking them for interviews. For the uninitiated, it’s usually the other way around.

          advertisement

          Their message? We’re still here. 

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          comprehensive

          The cancer drug shortage isn’t new — and neither are the solutions
          The cancer drug shortage isn’t new — and neither are the solutions

          PreparingachemotherapytreatmentatDukeCancerCenterinDurham,N.C.GerryBroome/APAyounggirl,maybe5or6year

          read more
          Covid vaccine financial winners and losers, from Pfizer to Novavax
          Covid vaccine financial winners and losers, from Pfizer to Novavax

          Illustration:ChristineKao/STAT;Photos:GettyIt’sbeenfouryearssinceCovid-19emerged,ignitingapandemicth

          read more
          Psychedelics group wrestles with new pharma identity
          Psychedelics group wrestles with new pharma identity

          OliviaGoldhill/STATDENVER—Hecouldhavebeenarockstar,areligiousicon,thewayecstaticapplausefromthousand

          read more

          States should stop sabotaging methadone treatment reform

          Somearguethattakingmethadoneathomeisfarbetterthantrudgingtoacliniceveryday.KevinD.Liles/APSincetheFo